Category: Early Drug Development

Building smarter early phase oncology programs for biotechs

How early engagement and an integrated CDMO-CRO model expedites drug development

Clinical Trial Design Strategies for IBS and IBD

Early Engagement with a CRO Partner: A Game Changer for Emerging Biotechs

Inflation Reduction Act Pipeline Considerations for Drug Developers

Coordinating the Cell Journey: Essentials in Early Clinical Development

Proactively Manage Central Lab Studies with a Powerful New Dashboard

The Evolution of Adaptive Protocols: Early Clinical Development

Six Factors for Biotech Companies to Consider When Choosing Next-Generation Contract GMP/CMC Laboratories